From immune heterogeneity to targeted therapies in IgG4-related disease.
PURPOSE OF REVIEW Recent advances in single-cell, spatial, and multiomic technologies have provided new insights into the immunopathogenesis and clinical heterogeneity of IgG4-related disease (IgG4-RD). At the same time, several mechanism-based therapies have entered clinical development. RECENT FINDINGS Recent studi...